NCT05034692

Brief Summary

Objective:The comparison between total laparoscopic colectomy with intracorporeal anastomosis by overlap method and laparoscopic-assisted colectomy with extracorporeal anastomosis for colon cancer surgery. Condition or disease:Left colon cancer Intervention/treatment: Procedure:Intracorporeal left colectomy Overlap anastomosis Procedure: Extracorporeal left colectomy convention anastomosis

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2021

Completed
7 months until next milestone

First Posted

Study publicly available on registry

September 5, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

March 21, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

October 24, 2022

Status Verified

October 1, 2022

Enrollment Period

2.8 years

First QC Date

February 6, 2021

Last Update Submit

October 20, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of early complications

    According to Clavein Dindo grading standards(The scale is divided into four levels, with the minimum(Ⅰ) and the maximum(Ⅳ) level. The higher the level that more severe symptoms.), the incidence of complications within one month after surgery, such as incision infection, bleeding, anastomotic leakage, ileus, etc., was counted

    one month after surgery

Secondary Outcomes (7)

  • anastomotic orifice stricture and torsion

    one month after surgery

  • the time of first flatus

    one month after surgery

  • the time of first defecation

    one month after surgery

  • the time of first oral feeding

    one month after surgery

  • postoperative hospitalization days

    one month after surgery

  • +2 more secondary outcomes

Study Arms (2)

Overlap group

EXPERIMENTAL

Total laparoscopic with intracorporeal anastomosis by overlap method

Procedure: Total laparoscopic with intracorporeal anastomosis by overlap method

Traditional group

ACTIVE COMPARATOR

Laparoscopic-assisted colectomy with extracorporeal anastomosis

Procedure: Laparoscopic-assisted colectomy with extracorporeal anastomosis

Interventions

After the intestinal canal was dissociated and vascularized, the intestinal canal was nuded and cut off, and the distal and proximal intestinal canals were overlapped by 6 cm

Overlap group

After the corresponding colon and blood vessels were dissociated and treated, the carbon dioxide pneumoperitoneum was removed. The appropriate length of the incision was cut at the corresponding position of the abdomen, and the incision protector was placed. The tumor was lifted together with the free intestinal canal to the outside of the abdomen. The intestinal canals at the quasi-dismembered sites on both sides of the tumor were nuded, and the colon-colon functional end-to-end anastomosis was performed.

Traditional group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA\<3 classification
  • kg/m2≤BMI≤30kg/m2
  • Neoplasm staging is T1-4a, N0-2, M0
  • No previous history of abdominal surgery
  • No previous history of neoplasm chemoradiotherapy
  • No status of ileus, bowel obstruction and active hemorrhage of the digestive tract

You may not qualify if:

  • Age\<18 years or \>75 years
  • ASA≥3 classification
  • BMI\<18kg/m2 or BMI\>30kg/m2
  • Neoplasm staging is T4b or M1 Underwent chemoradiotherapy Appeared status of ileus,bowel perforation or active hemorrhage of digestive tract Patients with pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

General Surgery Gastrointestinal Department,Tang-Du of Fourth Military Medical University

Xi'an, Shaanxi, 710000, China

RECRUITING

MeSH Terms

Conditions

Colonic Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Study Officials

  • Wang Nan, Doctor

    General surgery ,Tang Du of Fourth Military Medical University

    STUDY CHAIR

Central Study Contacts

Nan Wang, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2021

First Posted

September 5, 2021

Study Start

March 21, 2022

Primary Completion

December 20, 2024

Study Completion

December 31, 2025

Last Updated

October 24, 2022

Record last verified: 2022-10

Locations